天臣医疗
(688013)
| 流通市值：16.66亿 | | | 总市值：16.66亿 |
| 流通股本：8115.56万 | | | 总股本：8115.56万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 173,011,182.73 | 113,337,168.31 | 55,677,592.99 | 326,733,883.44 |
| 营业收入 | 173,011,182.73 | 113,337,168.31 | 55,677,592.99 | 326,733,883.44 |
| 二、营业总成本 | 166,860,167.64 | 109,762,773.92 | 52,954,345.86 | 243,879,907.75 |
| 营业成本 | 68,689,210.97 | 42,853,474.19 | 19,971,705.32 | 117,872,581.77 |
| 税金及附加 | 1,866,052.12 | 1,171,190.46 | 519,591.41 | 3,066,938.84 |
| 销售费用 | 32,031,430.49 | 20,807,392.05 | 9,688,586.06 | 47,672,256.37 |
| 管理费用 | 23,031,906.24 | 15,974,510.1 | 7,881,425.09 | 34,095,466.4 |
| 研发费用 | 34,534,199.74 | 25,004,240.93 | 12,848,086.66 | 51,302,319.64 |
| 财务费用 | 6,707,368.08 | 3,951,966.19 | 2,044,951.32 | -10,129,655.27 |
| 其中:利息费用 | 1,964,621.29 | 1,054,647.43 | 226,538.75 | 473,452.33 |
| 其中:利息收入 | 49,768.19 | 26,226.21 | 8,273.66 | 103,381.31 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 10,039,193.45 | 9,292,312.85 | 140,987.45 | 8,476,382.03 |
| 加:投资收益 | 771,626.68 | 361,339.03 | 5,867,694.33 | 2,768,145.01 |
| 资产处置收益 | 55,475.02 | 51,175.5 | 49,379.92 | 409,429.03 |
| 资产减值损失(新) | -136,821.02 | -136,821.02 | -253,480 | -186,605.72 |
| 信用减值损失(新) | 801,900.85 | 957,904.39 | 487,445.17 | -1,611,627 |
| 其他收益 | 1,128,897.64 | 733,169.45 | 596,864.98 | 2,902,503.56 |
| 四、营业利润 | 18,811,287.71 | 14,833,474.59 | 9,612,138.98 | 95,612,202.6 |
| 加:营业外收入 | - | - | - | 44,369.78 |
| 减:营业外支出 | 81,741.1 | 54,928.25 | 291.02 | 489,577.35 |
| 五、利润总额 | 18,729,546.61 | 14,778,546.34 | 9,611,847.96 | 95,166,995.03 |
| 减:所得税费用 | 2,223,091.12 | 1,037,927.73 | -81,120.84 | 9,981,570.99 |
| 六、净利润 | 16,506,455.49 | 13,740,618.61 | 9,692,968.8 | 85,185,424.04 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 16,506,455.49 | 13,740,618.61 | 9,692,968.8 | 85,185,424.04 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 16,506,455.49 | 13,740,618.61 | 9,692,968.8 | 85,185,424.04 |
| 扣除非经常损益后的净利润 | 6,865,380.82 | 5,073,030.67 | 4,109,050.45 | 74,235,859.47 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 0.17 | 0.12 | 1.06 |
| (二)稀释每股收益 | 0.2 | 0.17 | 0.12 | 1.05 |
| 八、其他综合收益 | 335,135.92 | 287,058.51 | 241,582.49 | -41,346.61 |
| 归属于母公司股东的其他综合收益 | 335,135.92 | 287,058.51 | 241,582.49 | -41,346.61 |
| 九、综合收益总额 | 16,841,591.41 | 14,027,677.12 | 9,934,551.29 | 85,144,077.43 |
| 归属于母公司股东的综合收益总额 | 16,841,591.41 | 14,027,677.12 | 9,934,551.29 | 85,144,077.43 |
| 公告日期 | 2026-10-31 | 2026-08-27 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |